Impact of post-therapy positron emission tomography on prognostic stratification and surveillance after chemoradiotherapy for cervical cancer

Cancer

Volumn 117, Issue 17, 2011, Pages 3981-3988

  Siva, Shankar ^a   Herschtal, Alan ^a   Thomas, Jessica M ^a   Bernshaw, David M ^a   Gill, Suki ^a   Hicks, Rodney J ^a   Narayan, Kailash ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

cervix cancer; fluorodeoxyglucose positron emission tomography; prognostic factors; radiotherapy; surveillance; survival

Indexed keywords

CISPLATIN; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; BRACHYTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURVIVAL; CHEMORADIOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PELVIS EXENTERATION; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; REVIEW; SALVAGE THERAPY; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR VOLUME; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RECURRENCE; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS;

EID: 80051947531     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25991     Document Type: Review

References (26)

1. World Health Organization. Global Burden of Disease Report, 2004 (2008 update). Geneva, Switzerland: WHO Press; 2008: 30.
2. Plummer M, Franceschi S,. Strategies for HPV prevention. Virus Res. 2002; 89: 285-293. (Pubitemid 35351547)
3. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999; 340: 1144.
4. Zola P, Fuso L, Mazzola S, et al. Follow-up strategies in gynecological oncology: searching appropriateness. Int J Gynecol Cancer. 2007; 17: 1186-1193. (Pubitemid 350077362)
5. Kew FM, Roberts AP, Cruickshank DJ,. The role of routine follow-up after gynecological malignancy. Int J Gynecol Cancer. 2005; 15: 413.
6. Bodurka-Bevers D, Morris M, Eifel PJ, et al. Post-therapy surveillance of women with cervical cancer: an outcomes analysis. Gynecol Oncol. 2000; 78: 187-193. (Pubitemid 30650352)
7. Samlal RA, Van Der Velden J, Van Eerden T, Schilthuis MS, Gonzalez Gonzalez D, Lammes FB,. Recurrent cervical carcinoma after radical hysterectomy: an analysis of clinical aspects and prognosis. Int J Gynecol Cancer. 1998; 8: 78-84. (Pubitemid 28119962)
8. Soisson AP, Geszler G, Soper JT, Berchuck A, Clarke-Pearson DL,. A comparison of symptomatology, physical examination, and vaginal cytology in the detection of recurrent cervical carcinoma after radical hysterectomy. Obstet Gynecol. 1990; 76: 106-109. (Pubitemid 20205229)
9. Kew FM, Galaal K, Manderville H,. Patients' views of follow-up after treatment for gynaecological cancer. J Obstet Gynaecol. 2009; 29: 135-142.
10. Narayan K, Fisher RJ, Bernshaw D, Shakher R, Hicks RJ,. Patterns of failure and prognostic factor analyses in locally advanced cervical cancer patients staged by positron emission tomography and treated with curative intent. Int J Gynecol Cancer. 2009; 19: 912.
11. Narayan K, Fisher RJ, Bernshaw D,. Patterns of failure and prognostic factor analyses in locally advanced cervical cancer patients staged by magnetic resonance imaging and treated with curative intent. Int J Gynecol Cancer. 2008; 18: 525-533. (Pubitemid 351668318)
12. MacManus MP, Hicks RJ, Matthews JP, et al. Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with nonsmall-cell lung cancer. J Clin Oncol. 2003; 21: 1285-1292. (Pubitemid 46606405)
13. Ware RE, Matthews JP, Hicks RJ, et al. Usefulness of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with a residual structural abnormality after definitive treatment for squamous cell carcinoma of the head and neck. Head Neck. 2004; 26: 1008-1017. (Pubitemid 39601219)
14. Duong CP, Hicks RJ, Weih L, et al. FDG-PET status following chemoradiotherapy provides high management impact and powerful prognostic stratification in esophageal cancer. Eur J Nucl Med Mol Imaging. 2006; 337: 770-778. (Pubitemid 43979684)
15. Kalff V, Duong C, Drummond EG, Matthews JP, Hicks RJ,. Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery. J Nucl Med. 2006; 47: 14-22. (Pubitemid 46768507)
16. Havrilesky LJ, Kulasingam SL, Matchar DB, Myers ER,. FDG-PET for management of cervical and ovarian cancer. Gynecol Oncol. 2005; 97: 183-191. (Pubitemid 40403692)
17. Schwarz JK, Siegel BA, Dehdashti F, Grigsby PW,. Association of post-therapy positron emission tomography with tumor response and survival in cervical carcinoma. JAMA. 2007; 298: 2289-2295. (Pubitemid 350146219)
18. Grigsby PW, Siegel BA, Dehdashti F, Mutch DG,. Post-therapy surveillance monitoring of cervical cancer by FDG-PET. Int J Radiat Oncol Biol Phys. 2003; 55: 907-913. (Pubitemid 36286992)
19. Brooks RA, Rader JS, Dehdashti F, et al. Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer. Gynecol Oncol. 2009; 112: 104-109.
20. Grigsby PW, Siegel BA, Dehdashti F, Rader J, Zoberi I,. Post-therapy (18F) fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome. J Clin Oncol. 2004; 22: 2167.
21. Maneo A, Landoni F, Cormio G, Colombo A, Mangioni C,. Radical hysterectomy for recurrent or persistent cervical cancer following radiation therapy. Int J Gynecol Cancer. 1999; 9: 295-301. (Pubitemid 29399361)
22. Zanagnolo V, Ming L, Gadducci A, et al. Surveillance procedures for patients with cervical carcinoma: a review of the literature. Int J Gynecol Cancer. 2009; 19: 194.
23. Morice P, Deyrolle C, Rey A, et al. Value of routine follow-up procedures for patients with stage I/II cervical cancer treated with combined surgery-radiation therapy. Ann Oncol. 2004; 15: 218.
24. Unger JB, Ivy JJ, Connor P, et al. Detection of recurrent cervical cancer by whole-body FDG PET scan in asymptomatic and symptomatic women. Gynecol Oncol. 2004; 94: 212-216. (Pubitemid 38950523)
25. Chung HH, Kim SK, Kim TH, et al. Clinical impact of FDG-PET imaging in post-therapy surveillance of uterine cervical cancer: from diagnosis to prognosis. Gynecol Oncol. 2006; 103: 165-170. (Pubitemid 44374686)
26. Corry J, Rischin D, Hicks RJ, Peters LJ,. The role of PET-CT in the management of patients with advanced cancer of the head and neck. Curr Oncol Rep. 2008; 10: 149-155. (Pubitemid 351395475)